Cell Genesys, Inc. - Earning & Dividend Analysis Snapshot

This detailed Report provides an Earnings and Dividends history for Cell Genesys, Inc.. Tabular results include up to a ten-year history of "as reported" Earnings per Share and Dividends per Share plus a calculation of the amount of earnings paid out over the year in dividends (i.e. Payout Ratio). Earnings and Dividends are presented on both a Quarterly and Annual basis. An annual Percent Change factor is calculated for both Earnings and Dividends.

Cell Genesys, Inc.. The Group's principal activities are researching, developing and commercializing novel biological therapies for patients with cancer. It currently has three product platforms: GVAX cancer vaccines, oncolytic virus therapies and cancer gene therapies. The Group conducts clinical trials in multiple types of cancer utilizing its GVAX cancer vaccines and oncolytic virus therapy product platforms. GVAX vaccines consist of irradiated tumor cells, genetically modified to secrete a hormone that stimulates the body's immune response to vaccines. Oncolytic virus therapies which employ genetically modified adenoviruses are engineered to selectively replicate in and kill cancer cells.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report